To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...
The Point-of-Care Molecular Diagnostics Market is experiencing robust expansion driven by rising demand for rapid, accurate, ...
Key market opportunities for Cas12 proteins include rising government investments in biotech, increased demand for ...
Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...
The future depends on collaboration between pharma and diagnostics companies to implement strategies that accelerate innovation, ensure regulatory alignment, and deliver local access at global scale ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Major change for rare disease treatments on way, signals MHRA: United Kingdom Tuesday, November 4, 2025, 13:00 Hrs [IST] The rulebook for rare disease therapies will be overhauled ...
Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback